메뉴 건너뛰기




Volumn 45, Issue 1, 2010, Pages 60-67

Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma

Author keywords

Cisplatin; Hepatocellular carcinoma; Prognosis; Transcatheter arterial infusion chemotherapy

Indexed keywords

ALBUMIN; CISPLATIN; IODINATED POPPYSEED OIL;

EID: 77949267722     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0109-8     Document Type: Article
Times cited : (28)

References (31)
  • 1
    • 0141491273 scopus 로고    scopus 로고
    • Hepatocellular carcinoma
    • DOI 10.1016/S0140-6736(03)14964-1
    • JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917 10.1016/S0140-6736(03)14964-1 14667750 (Pubitemid 37518510)
    • (2003) Lancet , vol.362 , Issue.9399 , pp. 1907-1917
    • Llovet, J.M.1    Burroughs, A.2    Bruix, J.3
  • 2
    • 0036085956 scopus 로고    scopus 로고
    • Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials
    • 10.1148/radiol.2241011262 12091661
    • C Cammà F Schepis A Orlando M Albanese L Shahied F Trevisani, et al. 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54 10.1148/radiol.2241011262 12091661
    • (2002) Radiology , vol.224 , pp. 47-54
    • Cammà, C.1    Schepis, F.2    Orlando, A.3    Albanese, M.4    Shahied, L.5    Trevisani, F.6
  • 3
    • 0037308133 scopus 로고    scopus 로고
    • Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
    • DOI 10.1053/jhep.2003.50047
    • JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 10.1053/jhep.2003.50047 1:CAS:528:DC%2BD3sXhsFeltrg%3D 12540794 (Pubitemid 36152543)
    • (2003) Hepatology , vol.37 , Issue.2 , pp. 429-442
    • Llovet, J.M.1    Bruix, J.2
  • 4
    • 0023857307 scopus 로고
    • Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial
    • 1:STN:280:DyaL1c%2FosVarsA%3D%3D 2826285
    • DY Lin YF Liaw TY Lee CM Lai 1988 Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial Gastroenterology 94 453 456 1:STN:280:DyaL1c%2FosVarsA%3D%3D 2826285
    • (1988) Gastroenterology , vol.94 , pp. 453-456
    • Lin, D.Y.1    Liaw, Y.F.2    Lee, T.Y.3    Lai, C.M.4
  • 5
    • 0025242359 scopus 로고
    • A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
    • 10.1016/0168-8278(90)90110-D 1:STN:280:DyaK3M%2Fnt12hsQ%3D%3D 2174933
    • G Pelletier A Roche O Ink ML Anciaux S Derhy P Rougier, et al. 1990 A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 181 184 10.1016/0168-8278(90) 90110-D 1:STN:280:DyaK3M%2Fnt12hsQ%3D%3D 2174933
    • (1990) J Hepatol , vol.11 , pp. 181-184
    • Pelletier, G.1    Roche, A.2    Ink, O.3    Anciaux, M.L.4    Derhy, S.5    Rougier, P.6
  • 6
    • 0029001687 scopus 로고
    • A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
    • Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire
    • Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256-61.
    • (1995) N Engl J Med. , vol.332 , pp. 1256-1261
  • 8
    • 0031801297 scopus 로고    scopus 로고
    • Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
    • DOI 10.1002/hep.510270617
    • J Bruix JM Llovet A Castells X Montana C Bru MC Ayuso, et al. 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1578 1583 10.1002/hep.510270617 1:STN:280:DyaK1c3otFKnsg%3D%3D 9620330 (Pubitemid 28264682)
    • (1998) Hepatology , vol.27 , Issue.6 , pp. 1578-1583
    • Bruix, J.1    Llovet, J.M.2    Castells, A.3    Montana, X.4    Bru, C.5    Del Carmen Ayuso, M.6    Vilana, R.7    Rodes, J.8
  • 9
    • 0036237822 scopus 로고    scopus 로고
    • Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma
    • DOI 10.1053/jhep.2002.33156
    • CM Lo H Ngan WK Tso CL Liu CM Lam RT Poon, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 10.1053/jhep.2002.33156 1:CAS:528:DC%2BD38XktF2hu7w%3D 11981766 (Pubitemid 34454013)
    • (2002) Hepatology , vol.35 , Issue.5 , pp. 1164-1171
    • Lo, C.-M.1    Ngan, H.2    Tso, W.-K.3    Liu, C.-L.4    Lam, C.-M.5    Poon, R.T.-P.6    Fan, S.-T.7    Wong, J.8
  • 10
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
    • DOI 10.1016/S0140-6736(02)08649-X
    • JM Llovet MI Real X Montana R Planas S Coll J Aponte, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739 10.1016/S0140-6736(02)08649-X 12049862 (Pubitemid 34607087)
    • (2002) Lancet , vol.359 , Issue.9319 , pp. 1734-1739
    • Llovet, J.M.1    Real, M.I.2    Montana, X.3    Planas, R.4    Coll, S.5    Aponte, J.6    Ayuso, C.7    Sala, M.8    Muchart, J.9    Sola, R.10    Rodes, J.11    Bruix, J.12
  • 11
    • 2942601262 scopus 로고    scopus 로고
    • Therapy for unresectable hepatocellular carcinoma: Review of the randomized clinical trials - II: Systemic and local non-embolization-based therapies in unresectable and advance hepatocellular carcinoma
    • DOI 10.1097/01.cad.0000131140.12228.bb
    • JD Schwartz AS Beutler 2004 Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma Anticancer Drugs 15 439 452 10.1097/01.cad.0000131140.12228.bb 1:CAS:528:DC%2BD2cXktlWqurs%3D 15166617 (Pubitemid 38736941)
    • (2004) Anti-Cancer Drugs , vol.15 , Issue.5 , pp. 439-452
    • Schwartz, J.D.1    Beutler, A.S.2
  • 12
    • 33845986704 scopus 로고    scopus 로고
    • Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
    • 1:CAS:528:DC%2BD2sXhtleqtrY%3D 17171782
    • M Minagawa M Makuuchi 2006 Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561 7567 1:CAS:528:DC%2BD2sXhtleqtrY%3D 17171782
    • (2006) World J Gastroenterol , vol.12 , pp. 7561-7567
    • Minagawa, M.1    Makuuchi, M.2
  • 13
    • 0027247841 scopus 로고
    • Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology
    • 10.1007/BF02602962 1:STN:280:DyaK2c%2Fgs1Cisw%3D%3D 8402781
    • T Imaeda Y Yamawaki M Seki H Goto G Iinuma M Kanematsu, et al. 1993 Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology Cardiovasc Intervent Radiol 16 209 213 10.1007/BF02602962 1:STN:280:DyaK2c%2Fgs1Cisw%3D%3D 8402781
    • (1993) Cardiovasc Intervent Radiol , vol.16 , pp. 209-213
    • Imaeda, T.1    Yamawaki, Y.2    Seki, M.3    Goto, H.4    Iinuma, G.5    Kanematsu, M.6
  • 14
    • 0023197221 scopus 로고
    • Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents
    • 1:STN:280:DyaL2s7ns1Cjsw%3D%3D 3031724
    • K Takayasu Y Shima Y Muramatsu N Moriyama T Yamada M Makuuchi, et al. 1987 Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 345 351 1:STN:280: DyaL2s7ns1Cjsw%3D%3D 3031724
    • (1987) Radiology , vol.163 , pp. 345-351
    • Takayasu, K.1    Shima, Y.2    Muramatsu, Y.3    Moriyama, N.4    Yamada, T.5    Makuuchi, M.6
  • 15
    • 0034071842 scopus 로고    scopus 로고
    • Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma
    • 10.1159/000012115 1:STN:280:DC%2BD3c3pvFajtQ%3D%3D 10838494
    • T Okusaka S Okada H Ueno M Ikeda M Yoshimori K Shimada, et al. 2000 Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma Oncology 58 293 299 10.1159/000012115 1:STN:280:DC%2BD3c3pvFajtQ%3D%3D 10838494
    • (2000) Oncology , vol.58 , pp. 293-299
    • Okusaka, T.1    Okada, S.2    Ueno, H.3    Ikeda, M.4    Yoshimori, M.5    Shimada, K.6
  • 16
    • 77949263981 scopus 로고    scopus 로고
    • Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial
    • abstr 4643
    • Okusaka T, Sato T, Hinotsu S, Shioyama Y, Kasugai H, Tanaka K, et al. Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: results of a multicenter randomized phase III trial. J Clin Oncol 2007 ASCO Annual Meeting Proceedings. 2007;25:18S (abstr 4643).
    • (2007) J Clin Oncol 2007 ASCO Annual Meeting Proceedings , vol.25
    • Okusaka, T.1    Sato, T.2    Hinotsu, S.3    Shioyama, Y.4    Kasugai, H.5    Tanaka, K.6
  • 17
    • 1642525643 scopus 로고    scopus 로고
    • Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma
    • DOI 10.1159/000076331
    • M Ikeda S Maeda J Shibata R Muta H Ashihara M Tanaka, et al. 2004 Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma Oncology 66 24 31 10.1159/000076331 1:CAS:528:DC%2BD2cXitlyitLo%3D 15031595 (Pubitemid 38410676)
    • (2004) Oncology , vol.66 , Issue.1 , pp. 24-31
    • Ikeda, M.1    Maeda, S.2    Shibata, J.3    Muta, R.4    Ashihara, H.5    Tanaka, M.6    Fujiyama, S.7    Tomita, K.8
  • 18
    • 18444381151 scopus 로고    scopus 로고
    • Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma
    • DOI 10.1159/000059570
    • T Okusaka S Okada H Ueno M Ikeda R Iwata H Furukawa, et al. 2002 Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma Oncology 62 228 233 10.1159/000059570 1:CAS:528:DC%2BD38Xlt1yls7g%3D 12065870 (Pubitemid 34639056)
    • (2002) Oncology , vol.62 , Issue.3 , pp. 228-233
    • Okusaka, T.1    Okada, S.2    Ueno, H.3    Ikeda, M.4    Iwata, R.5    Furukawa, H.6    Takayasu, K.7    Moriyama, N.8    Sato, T.9    Sato, K.10
  • 20
    • 35448994259 scopus 로고    scopus 로고
    • Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma
    • DOI 10.1007/s00535-007-2099-8
    • K Uka H Aikata S Takaki D Miki T Kawaoka SC Jeong, et al. 2007 Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma J Gastroenterol 42 845 853 10.1007/s00535-007-2099-8 1:CAS:528:DC%2BD2sXhtFyrur3L 17940838 (Pubitemid 47617463)
    • (2007) Journal of Gastroenterology , vol.42 , Issue.10 , pp. 845-853
    • Uka, K.1    Aikata, H.2    Takaki, S.3    Miki, D.4    Kawaoka, T.5    Jeong, S.C.6    Takahashi, S.7    Toyota, N.8    Ito, K.9    Chayama, K.10
  • 21
    • 42649086177 scopus 로고    scopus 로고
    • Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma
    • DOI 10.1111/j.1872-034X.2008.00338.x
    • M Yoshikawa N Ono H Yodono T Ichida H Nakamura 2008 Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma Hepatol Res 38 474 483 10.1111/j.1872-034X.2008.00338. x 1:CAS:528:DC%2BD1cXptlajsLw%3D 18430093 (Pubitemid 351593948)
    • (2008) Hepatology Research , vol.38 , Issue.5 , pp. 474-483
    • Yoshikawa, M.1    Ono, N.2    Yodono, H.3    Ichida, T.4    Nakamura, H.5
  • 22
    • 0033972909 scopus 로고    scopus 로고
    • A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
    • DOI 10.1002/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I
    • L Lladó J Virgili J Figueras C Valls J Dominguez A Rafecas, et al. 2000 A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 50 57 10.1002/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I 10618605 (Pubitemid 30027678)
    • (2000) Cancer , vol.88 , Issue.1 , pp. 50-57
    • Llado, L.1    Virgili, J.2    Figueras, J.3    Valls, C.4    Dominguez, J.5    Rafecas, A.6    Torras, J.7    Fabregat, J.8    Guardiola, J.9    Jaurrieta, E.10
  • 25
    • 0024468181 scopus 로고
    • Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma
    • 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E 1:STN:280:DyaK3c%2Fgt1Onsw%3D%3D 2477131
    • J Shibata S Fujiyama T Sato S Kishimoto S Fukushima M Nakano 1989 Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma Cancer 64 1586 1594 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E 1:STN:280:DyaK3c%2Fgt1Onsw%3D%3D 2477131
    • (1989) Cancer , vol.64 , pp. 1586-1594
    • Shibata, J.1    Fujiyama, S.2    Sato, T.3    Kishimoto, S.4    Fukushima, S.5    Nakano, M.6
  • 26
    • 0028220635 scopus 로고
    • A randomized trial of intrahepatic arterial infusion of 4?-epidoxorubicin with lipiodol versus 4?-epidoxorubicin alone in the treatment of hepatocellular carcinoma
    • 10.1007/BF00686689 8137478
    • M Yoshikawa H Saisho M Ebara T Iijima S Iwama F Endo, et al. 1994 A randomized trial of intrahepatic arterial infusion of 4?-epidoxorubicin with lipiodol versus 4?-epidoxorubicin alone in the treatment of hepatocellular carcinoma Cancer Chemother Pharmacol 33 Suppl S149 S152 10.1007/BF00686689 8137478
    • (1994) Cancer Chemother Pharmacol , vol.33 , Issue.SUPPL
    • Yoshikawa, M.1    Saisho, H.2    Ebara, M.3    Iijima, T.4    Iwama, S.5    Endo, F.6
  • 27
    • 1442277082 scopus 로고    scopus 로고
    • Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma
    • DOI 10.1023/B:DRUG.0000011793.72775.d1
    • T Okusaka S Okada T Nakanishi S Fujiyama Y Kubo 2004 Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma Invest New Drugs 22 169 176 10.1023/B:DRUG.0000011793.72775.d1 1:CAS:528:DC%2BD2cXisleitg%3D%3D 14739665 (Pubitemid 38270472)
    • (2004) Investigational New Drugs , vol.22 , Issue.2 , pp. 169-176
    • Okusaka, T.1    Okada, S.2    Nakanishi, T.3    Fujiyama, S.4    Kubo, Y.5
  • 28
    • 0021965806 scopus 로고
    • Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
    • DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0. CO;2-E
    • K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa, et al. 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928 10.1002/1097-0142(19850815) 56:4<918::AID-CNCR2820560437>3.0.CO;2-E 1:STN:280:DyaL2M3lsVaqtw%3D%3D 2990661 (Pubitemid 15228292)
    • (1985) Cancer , vol.56 , Issue.4 , pp. 918-928
    • Okuda, K.1    Ohtsuki, T.2    Obata, H.3
  • 29
    • 0015854966 scopus 로고
    • Transection of the oesophagus for bleeding oesophageal varices
    • 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
    • RNH Pugh IM Murry-Lyon JL Dawson MC Pietroni R Williams 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
    • (1973) Br J Surg , vol.60 , pp. 646-649
    • Pugh, R.N.H.1    Murry-Lyon, I.M.2    Dawson, J.L.3    Pietroni, M.C.4    Williams, R.5
  • 30
    • 46949099956 scopus 로고    scopus 로고
    • Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma
    • DOI 10.1007/s00535-008-2164-y
    • KZ Luo T Itamoto H Amano A Oshita Y Ushitora Y Tanimoto, et al. 2008 Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma J Gastroenterol 43 369 377 10.1007/s00535-008-2164-y 1:CAS:528: DC%2BD1cXns1egu7g%3D 18592155 (Pubitemid 351958901)
    • (2008) Journal of Gastroenterology , vol.43 , Issue.5 , pp. 369-377
    • Luo, K.-Z.1    Itamoto, T.2    Amano, H.3    Oshita, A.4    Ushitora, Y.5    Tanimoto, Y.6    Ohdan, H.7    Tashiro, H.8    Asahara, T.9
  • 31
    • 47949116252 scopus 로고    scopus 로고
    • SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma
    • 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
    • JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3    Hilgard, P.4    Gane, E.5    Blanc, J.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.